Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
VRCA
#4015
Verrica Pharmaceuticals Inc. Common Stock
5.965
0
USD
+4.28%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+4.28%
Aylık Değişim
-2.05%
6 aylık değişim
-0.91%
Yıllık Değişim
-0.91%
Önceki Kapanış
5.720
0
Open
5.910
0
Bid
Ask
Low
5.865
0
High
5.965
0
Hacim
72
Piyasalar
ABD Borsası
Sağlık Hizmetleri
VRCA
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
9.18 M
9.25 M
9.45 M
9.49 M
17.18 M
—
Valuation ratios
Enterprise value
49.8 M
39.93 M
60 M
42.09 M
113.19 M
255.21 M
Price to earnings ratio
-0.47
-0.39
-0.69
-1.52
-4.95
-7.55
Price to sales ratio
4.79
3.81
3.82
1.31
2.49
11.43
Price to cash flow ratio
-0.6
-0.45
-0.72
-0.96
-5.02
-7.16
Price to book ratio
-3.68
-0.32
-0.41
-0.57
3.58
2.28
Enterprise value to EBITDA ratio
-0.74
-0.7
-1.5
-2.37
-9.28
-13.85
Profitability ratios
Return on assets %
-0.3
-0.23
0.01
-0.01
-0.17
-0.4
Return on equity %
1.64
0.52
-0.01
0.02
-0.33
0.2
Return on invested capital %
-149.28
—
—
—
-126.38
—
Gross margin %
-132.56
79.65
100
97.21
98.04
374.89
Operating margin %
-3 316.86
-236.41
11.89
11.34
-141.24
-354.42
EBITDA margin %
-3 504.65
-252.81
12.88
9.32
-140.98
-371.59
Net margin %
-4 709.88
-283.28
1.61
-1.91
-158.56
-442.15
Liquidity ratios
Quick ratio
1.68
1.26
1.17
1.18
2.45
6.06
Current ratio
1.76
1.34
1.26
1.25
2.59
6.44
Inventory turnover
—
—
—
0.17
0.04
—
Asset turnover
0.01
0.07
0.31
0.36
0.12
0.86
Solvency ratios
Debt to assets ratio
0.59
0.68
0.65
0.54
0.01
1.88
Debt to equity ratio
-3.23
-1.54
-1.45
-1.31
0.02
-4.27
Long term debt to total assets ratio
0.57
0.66
0.63
0.53
0
1.82
Long term debt to total equity ratio
-3.14
-1.5
-1.41
-1.27
0
-4.17
Per share metrics
Operating cash flow per share
-3.1
-1.34
-1.06
1.02
-0.43
-1.81
EBIT per share
-2.36
-0.93
0.16
0.13
-0.68
-1.33
EBITDA per share
-2.33
-0.92
0.17
0.14
-0.67
-1.28
Total debt per share
6.15
3.02
2.67
2.35
0.05
8.09
Cash per share
1.93
1.05
1.62
2.22
2.83
7.73
Net current asset value per share
9.88
4.16
3.88
3.82
3.99
15.85
Tangible book value per share
-1.9
-1.96
-1.84
-1.8
2.32
-3.27
Working capital per share
4.28
1.06
0.8
0.78
2.45
5.09
Book value per share
-1.9
-1.96
-1.84
-1.8
2.32
-3.27
Haberler
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript
Verrica Pharmaceuticals hisseleri, YCANTH’in Japonya’da piyasaya sürülmesiyle yükseldi
Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan
Verrica’s partner launches molluscum treatment in Japan
Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why
New Strong Buy Stocks for February 2nd
How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%
Verrica Pharmaceuticals hisseleri TD Cowen’ın Al tavsiyesini yinelemesiyle yükseldi
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating
Verrica doses first patient in phase 3 trial for common wart treatment
Verrica Pharmaceuticals yönetim kuruluna Charles Frantzreb’i atadı ve hisse teşviklerini onayladı
Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants